HIV-infected long-term nonprogressors display a unique correlative pattern between the interleukin-7/interleukin-7 receptor circuit and T-cell homeostasis

HIV Medicine

Volumn 10, Issue 7, 2009, Pages 422-431

  Marchetti, Glulia ^a   Riva, A ^b   Cesari, M ^b   Bellistri G M ^a   Gianelli, E ^b   Casabianca, A ^c   Orlandi, C ^c   Magnani, M ^c   Meroni, L ^b   D'Arminio Monforte, A ^a   Mussini, C ^d   Cossarizza, A ^e   Galli, M ^b   Gori, A ^f   Paraninfo, Giuseppe ^g   Carosi, Giampiero ^g   Sciandra, Maurizio ^h   Di Perri, Giovanni ^h   Quinzan, Gianpaolo ⁱ   Suter, Fredy ⁱ   Concia, Ercole ^j   Lattuada, Emanuele ^j   Rizzardini, Giuliano ^b   Capetti, Amedeo ^b   Beretta, Rosangela ^b   Fasolo, Michela ^b   Mazzotta, Francesco ^k   Di Pietro, Massimo ^k   Colombo, Chiara ^l   Santoro, Domenico ^l   more..

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF URBINO   (Italy)

^d UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^e UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^f SAN GERARDO HOSPITAL   (Italy)

^g UNIVERSITY OF BRESCIA   (Italy)

^h UNIVERSITY OF TURIN   (Italy)

ⁱ OSPEDALI RIUNITI   (Italy)

^j UNIVERSITY HOSPITAL OF VERONA   (Italy)

^k SANTA MARIA ANNUNZIATA HOSPITAL   (Italy)

^l Division of Infectious Diseases   (Italy)

more..

Author keywords

Homeostasis; Interleukin 7 interleukin 7R; LTNP; T cell

Indexed keywords

INTERLEUKIN 7; INTERLEUKIN 7 RECEPTOR ALPHA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ARTICLE; CD4 LYMPHOCYTE COUNT; CD4 LYMPHOCYTE PERCENTAGE; CELL METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE COURSE; DISEASE DURATION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; T LYMPHOCYTE;

ADULT; AGED; CD4 LYMPHOCYTE COUNT; CROSS-SECTIONAL STUDIES; DOWN-REGULATION; FEMALE; GENE REARRANGEMENT, T-LYMPHOCYTE; HIV INFECTIONS; HIV LONG-TERM SURVIVORS; HOMEOSTASIS; HUMANS; INTERLEUKIN-7; KI-67 ANTIGEN; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; RECEPTORS, INTERLEUKIN-7; T-LYMPHOCYTES; THYMUS GLAND;

EID: 67650682469     PISSN: 14642662     EISSN: 14681293     Source Type: Journal    
DOI: 10.1111/j.1468-1293.2009.00710.x     Document Type: Article

References (47)

1. Douek DC. Disrupting T-cell homeostasis: How HIV-1 infection causes disease. AIDS Rev 2003; 5: 172-177.
2. Grossman Z, Herbeman R. T-cell homeostasis in HIV infection is neither failing nor blind: Modified cell counts reflect an adaptive response of the host. Nat Med 1997; 3: 468-490.
3. Buchbinder SP, Katz MH, Hessol NA, O'Malley PM, Holmberg SD. Long-term HIV-1 infection without immunologic progression. AIDS 1994; 8: 1123-1128.
4. Keet IP, Krol A, Klein MR et al. Characteristics of long-term asymptomatic infection with human immunodeficiency virus type 1 in men with normal and low CD4 cell counts. J Infect Dis 1994; 169: 1236-1243.
5. Geginat J, Sallusto F, Lanzavecchia A. Cytokine-driven proliferation and differentiation of human naïve, central memory, and effector memory CD4 T cells. J Exp Med 2001; 194: 1711-1719.
6. Jaleco S, Swainson L, Dardalhon V et al. Homeostasis of naïve and memory CD4 T cells: IL-2 and IL-7 differentially regulate the balance between proliferation and Fas-mediated apoptosis. J Immunol 2003; 171: 61-68.
7. Judge AD, Zhang X, Fujii H, Surh CD, Sprent J. Interleukin 15 controls both proliferation and survival of a subset of memory-phenotype CD8 T cells. J Exp Med 2002; 196: 935-946.
8. Kondrack RM, Harbertson J, Tan JT et al. Interleukin 7 regulates the survival and generation of memory CD4 cells. J Exp Med 2003; 198: 1797-1806.
9. Schluns KS, Lefrancois L. Cytokine control of memory T-cell development and survival. Nat Rev Immunol 2003; 3: 269-279.
10. Fry T, Connick E, Falloon J et al. A potential role for interleukin-7 in T-cell homeostasis. Blood 2001; 97: 2983-2990.
11. Schluns KS, Kieper WC, Jameson SC, Lefrancois L. Interleukin-7 mediates the homeostasis of naïve and memory CD8 T cells in vivo. Nat Immunol 2000; 1: 426-432.
12. Napolitano L, Grant R, Deeks S et al. Increased production of IL-7 accompanies HIV-1-mediated T-cell depletion: Implications for T-cell homeostasis. Nat Med 2001; 7: 73-79.
13. Llano A, Barretina J, Gutierrez A et al. Interleukin-7 in plasma correlates with CD4 T-cell depletion and may be associated with emergence of syncytium-inducing variants in human immunodeficiency virus type 1-positive individuals. J Virol 2001; 75: 10319-10325.
14. Mastroianni CM, Forcina G, d'Ettorre G et al. Circulating levels of interleukin-7 in antiretroviral-naïve and highly active antiretroviral therapy-treated HIV-infected patients. HIV Clin Trials 2001; 2: 108-112.
15. Fluur C, Rethi B, Thang PH et al. Relationship between serum IL-7 concentrations and lymphopenia upon different levels of HIV immune control. AIDS 2007; 21: 1048-1050.
16. Carini C, McLane M, Mayer K, Essex M. Dysregulation of interleukin-7 receptor may generate loss of cytotoxic T cell response in human immunodeficiency virus type 1 infection. Eur J Immunol 1994; 24: 2921-2937.
17. MacPherson J, Fex C, Sanchez-Dardon J, Hawley-Foss N, Angel J. Interleukin-7 receptor expression on CD8 T cells is reduced in HIV infection and partially restored with effective antiretroviral therapy. J AIDS 2001; 28: 454-457.
18. Vingerhoets J, Bisalinkumi E, Penne G et al. Altered receptor expression and decreased sensitivity of T-cells to the stimulatory cytokines IL-2, IL-7 and IL-12 in HIV infection. Immunol Lett 1998; 61: 53-61.
19. Paiardini M, Cervasi B, Albrecht H et al. Loss of CD127 expression defines an expansion of effector CD8 T cells in HIV-infected individuals. J Immunol 2005; 174: 2900-2909.
20. Rethi B, Fluur C, Atlas A et al. Loss of IL-7R alpha is associated with CD4 T-cell depletion, high interleukin-7 levels and CD28 down-regulation in HIV infected patients. AIDS 2005; 19: 2077-2086.
21. Colle JH, Moreau JL, Fontanet A et al. Regulatory dysfunction of the interleukin-7 receptor in CD4 and CD8 lymphocytes from HIV-infected patients - effects of antiretroviral therapy. J Acquir Immune Defic Syndr 2006; 42: 277-285.
22. Koesters SA, Alimonti JB, Wachihi C et al. IL-7R alpha expression on CD4 T lymphocytes decreases with HIV disease progression and inversely correlates with immune activation. Eur J Immunol 2006; 36: 336-344.
23. Sasson SC, Zaunders JJ, Zanetti G et al. Increased plasma interleukin-7 level correlates with decreased CD127 and Increased CD132 extracellular expression on T cell subsets in patients with HIV-1 infection. J Infect Dis 2006; 193: 505-514.
24. Puel A, Ziegler SF, Buckley RH, Leonard WJ. Defective IL7R expression in T(-)B(+)NK(+) severe combined immunodeficiency. Nat Genet 1998; 20: 394-397.
25. Roifman CM, Zhang J, Chitayat D, Sharfe N. A partial deficiency of interleukin-7R alpha is sufficient to abrogate T-cell development and cause severe combined immunodeficiency. Blood 2000; 96: 2803-2807.
26. Verschuren M, Wolvers-Tettro I, Breit T et al. Preferential rearrangements of the T cell receptor-delta-deleting elements in human T cells. J Immunol 1997; 158: 1208-1216.
27. Al-Harthi L, Marchetti G, Steffens C et al. Detection of T cell receptor circles (TRECs) as biomarkers for de novo T cell synthesis using a quantitative polymerase chain reaction-enzyme linked immunosorbent assay (PCR-ELISA). J Immun Meth 2000; 237: 187-197.
28. Saiki RK, Scharf S, Faloona F et al. Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 1985; 230: 1350-1354.
29. Hazenberg M, Otto S, Cohen Stuart J et al. Increased cell division but not thymic dysfunction rapidly affects the T-cell receptor excision circle content of the naïve T cell population in HIV-1 infection. Nat Med 2000; 6: 1036-1042.
30. Kestens L, Vanham G, Gigase P et al. Expression of activation antigens, HLA-DR and CD38, on CD8 lymphocytes during HIV-1 infection. AIDS 1992; 6: 793-797.
31. Levacher M, Hulstaert F, Tallet S et al. The significance of activation markers on CD8 lymphocytes in human immunodeficiency syndrome: Staging and prognostic value. Clin Exp Immunol 1992; 90: 376-382.
32. Boutboul F, Puthier D, Appay V et al. Modulation of interleukin-7 receptor expression characterizes differentiation of CD8 T cells specific for HIV, EBV and CMV. AIDS 2005; 19: 1981-1986.
33. Mazzucchelli R, Durum SK. Interleukin-7 receptor expression: Intelligent design. Nat Rev Immunol 2007; 7: 144-154.
34. Douek DC, McFarland RD, Keiser PH et al. Changes in thymic function with age and during the treatment of HIV infection. Nature 1998; 396: 690-695.
35. Zhang L, Lewin SR, Markowitz M et al. Measuring recent thymic emigrants in blood of normal and HIV-1-infected individuals before and after effective therapy. J Exp Med 1999; 190: 725-732.
36. Poulin J-F, Viswanathan M, Harris J et al. Direct evidence for thymic function in adult humans. J Exp Med 1999; 190: 479-486.
37. Richardson MW, Sverstiuk AE, Gracely EJ et al. T-cell receptor excision circles (TRECs) and maintenance of long-term non-progression status in HIV-1 infection. AIDS 2003; 17: 915-917.
38. Nobile M, Correa R, Borghans JA et al. De novo T-cell generation in patients at different ages and stages of HIV-1 disease. Blood 2004; 104: 470-477.
39. Muthukumar A, Wozniakowski A, Gauduin MC et al. Elevated interleukin-7 levels not sufficient to maintain T-cell homeostasis during simian immunodeficiency virus-induced disease progression. Blood 2004; 103: 973-979.
40. Park JH, Yu Q, Erman B et al. Suppression of IL7R alpha transcription by IL-7 and other prosurvival cytokines: A novel mechanism for maximizing IL-7-dependent T cell survival. Immunity 2004; 21: 289-302.
41. Mackall CL, Fry TJ, Bare C et al. IL-7 increases both thymic-dependent and thymic-independent T-cell regeneration after bone marrow transplantation. Blood 2001; 97: 1491-1497.
42. Scripture-Adams DD, Brooks DG, Korin YD, Zack JA. Interleukin-7 induces expression of latent human immunodeficiency virus type 1 with minimal effects on T-cell phenotype. J Virol 2002; 76: 13077-13082.
43. Fry TJ, Moniuszko M, Creekmore S et al. IL-7 therapy dramatically alters peripheral T-cell homeostasis in normal and SIV-infected nonhuman primates. Blood 2003; 101: 2294-2299.
44. Rosenberg SA, Sportes C, Ahmadzadeh M et al. IL-7 administration to humans leads to expansion of CD8 and CD4 cells but a relative decrease of CD4 T-regulatory cells. J Immunother 2006; 29: 313-319.
45. Sereti I, Aga E, Spritzler J et al. rhIL7 in HIV-1-infected subjects with CD4 T-cell count > 100cells/μL and viral load <50,000 copies/mL: Results from a randomized, placebo-controlled, Double-blinded Study (ACTG5214). 14th Conference on Retroviruses and Opportunistic Infections, Los Angeles, CA, February 2007 [Abstract 128].
46. Levy Y, Weiss L, Viard J et al. Repeated r-hIL-7 doses improve T-cell recovery in HIV-1-infected patients enrolled in a phase I/II multicentric study, 14th Conference on Retroviruses and Opportunistic Infections, Los Angeles, CA, February 2007 [Abstract 127].
47. Levy Y, Weiss L, Goujard C et al. Sustained immunological efficacy of repeated r-hIL-7 doses in HIV-1 infected patients. Long-term follow-up of a phase I/II multicentric study, 15th Conference on Retroviruses and Opportunistic Infections, Boston, MA, February 2008 [Abstract 708].